Literature DB >> 11176455

Evaluation of gene transfer efficiency by viral vectors to murine bladder epithelium.

D R Siemens1, J C Austin, W A See, J Tartaglia, T L Ratliff.   

Abstract

PURPOSE: In pre-clinical gene therapy studies of bladder cancer there is tremendous variation in the ability of viral vectors to deliver genetic material to bladder epithelium. Possible explanations for this variability may involve the physical parameters of delivering vectors in these experimental models. We examined the effects of intravesical volume and pressure during instillation as well as chemical modification of the bladder epithelium on subsequent gene expression in the bladder in mice.
MATERIALS AND METHODS: Female C57B1/6 mice underwent intravesical instillation of the replication restricted canarypox virus (ALVAC) recombinant for the reporter genes luciferase or beta-galactosidase. Similar viral titers were instilled at different volumes and a pressure transducer measured intravesical pressure when the vector was instilled. Also, various agents, including 0.6 N hydrochloric acid, 0.4% oxychlorosene, poly-L-lysine and 0.25 M. ammonium chloride, were used to modify the bladder surface before vector instillation and then assayed for transgene expression.
RESULTS: As expected, maximum intravesical pressure measured during instillation was significantly greater in mice instilled with a higher volume (33.1 versus 9.8 mm. Hg). Significantly more gene expression was detected in bladders instilled with a higher volume of viral vectors (p <0.05). Likewise, higher instillation pressures resulted in higher transgene expression in distant organs. Modification of the bladder epithelium with agents such as oxychlorosene and poly-L-lysine resulted in elevated gene expression with only minimal increases in systemic activity.
CONCLUSIONS: Significant differences in gene expression are achieved by varying physical parameters during intravesical instillation. Increased gene expression associated with larger volume instillation may be responsible for some reported variability of gene transfer to the bladder. Alternate manipulations, such as modifying the bladder surface, may be done to enhance gene transfer to the urothelium without increasing systemic distribution.

Entities:  

Mesh:

Year:  2001        PMID: 11176455     DOI: 10.1097/00005392-200102000-00091

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

Review 1.  Recent advances in intravesical drug/gene delivery.

Authors:  Pradeep Tyagi; Pao-Chu Wu; Michael Chancellor; Naoki Yoshimura; Leaf Huang
Journal:  Mol Pharm       Date:  2006 Jul-Aug       Impact factor: 4.939

2.  Targeting gene expression of the mouse uroplakin II promoter to human bladder cells.

Authors:  Hongjian Zhu; Zhiqing A Zhang; Chunxiao Xu; Guojin Huang; Xiangfu Zeng; Shoushun Wei; Zhiwen Zhang; Yinglu Guo
Journal:  Urol Res       Date:  2003-02-18

3.  An orthotopic bladder cancer model for gene delivery studies.

Authors:  Laura Kasman; Christina Voelkel-Johnson
Journal:  J Vis Exp       Date:  2013-12-01       Impact factor: 1.355

4.  Herpes simplex virus vector-mediated gene delivery for the treatment of lower urinary tract pain.

Authors:  W F Goins; J R Goss; M B Chancellor; W C de Groat; J C Glorioso; N Yoshimura
Journal:  Gene Ther       Date:  2009-02-26       Impact factor: 5.250

5.  Polymer-enhanced delivery increases adenoviral gene expression in an orthotopic model of bladder cancer.

Authors:  Helen Gosnell; Laura M Kasman; Thrimoorthy Potta; Lucas Vu; Elizabeth Garrett-Mayer; Kaushal Rege; Christina Voelkel-Johnson
Journal:  J Control Release       Date:  2013-12-24       Impact factor: 9.776

6.  Tumor establishment features of orthotopic murine bladder cancer models.

Authors:  Jin Seok Lee; Min Ho Bae; Sung Ho Choi; Sang Hun Lee; Young Sam Cho; Heung Jae Park; Chil Hun Kwon; Kwan Joong Joo
Journal:  Korean J Urol       Date:  2012-06-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.